Granulomatosis with Polyangiitis: A small-vessel necrotizing vasculitis characterised by the association of inflammation of the vessel wall and peri- and extravascular granulomatosis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
559 |
4. Check minimum number of eventsNone |
559 |
5. Include endpointsNone |
559 |
6. Filter based on genotype QC (FinnGen only) |
559 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M31
- Name in latin
- Granulomatosis Wegener
Similar endpoints
↥List of similar endpoints to
Wegener granulomatosis
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies (FG)
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2962 | 1497 | 1441 |
| Only index persons | 2449 | 1266 | 1183 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 60.38 | 61.29 | 59.32 |
| Only index persons | 59.11 | 60.06 | 58.09 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 559 | 293 | 266 |
| Unadjusted period prevalence (%) | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | 55.52 | 54.63 | 56.50 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 503
- Matched controls
- 5029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
323.0
438
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
37.4
233.9
323
230
L04AX01
ATC
azathioprine; systemic
56.3
217.7
259
93
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
205.8
183
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
159.0
144
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
21.2
121.7
190
140
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
9.4
114.8
353
1004
L04AA06
ATC
mycophenolic acid; systemic
73.4
113.0
127
23
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
107.2
99
*
H02AB06
ATC
prednisolone; systemic
9.3
103.1
410
1620
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
16.4
89.4
152
129
L01AA01
ATC
cyclophosphamide; systemic
251.3
84.2
84
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
59.0
82.3
96
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.4
79.4
372
1539
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
78.2
73
*
M05BA04
ATC
alendronic acid; oral
11.4
75.4
153
185
DHA10
NOMESCO Finland
Biopsy of cavity of nose
67.9
74.6
85
15
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
16.4
70.5
118
92
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
10.4
68.6
146
190
UDH02
NOMESCO Finland
Rhinopharyngoscopy
10.7
63.8
132
161
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
56.3
53
*
TGC00
NOMESCO Finland
Bronchial lavation
21.4
55.5
83
46
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
24.0
52.9
76
37
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
25.0
52.8
75
35
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.4
51.7
107
127
H02AB04
ATC
methylprednisolone; systemic
5.8
49.8
164
387
ZX120
NOMESCO Finland
Intravenous
7.1
49.2
134
246
1XC02
NOMESCO Finland
NA
49.2
44.1
53
12
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.6
43.8
78
67
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
43.4
41
*
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
43.4
41
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.0
42.6
114
201
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
35.4
42.0
54
17
Z94.0
ICD-10 Finland
Kidney transplant status
35.2
37.4
48
15
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
36.9
35
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.9
36.7
113
236
A11CC03
ATC
alfacalcidol; systemic
14.9
36.6
62
47
KA1AE
NOMESCO Finland
Kidney ultrasound examination
14.6
36.2
62
48
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.7
35.0
192
713
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
34.8
33
*
R50.9
ICD-10 Finland
Fever, unspecified
4.6
33.8
134
368
A12AA04
ATC
calcium carbonate; oral
22.9
33.3
48
23
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
348.8
33.3
33
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
32.7
31
*
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
31.6
30
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
30.9
131
381
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
7.3
30.5
77
122
N18.8
ICD-10 Finland
Other chronic renal failure
13.3
30.0
53
44
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.0
29.8
105
252
A02BC02
ATC
pantoprazole; systemic
3.0
27.4
376
2492
TDM10
NOMESCO Finland
Puncture of maxillary antrum
8.8
26.8
59
75
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.8
26.8
55
62
B03XA02
ATC
darbepoetin alfa; parenteral
15.4
26.7
44
31
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
26.5
167
662
J31.0
ICD-10 Finland
Chronic rhinitis
5.4
26.4
84
179
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
26.3
25
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
13.2
26.1
46
38
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
11.9
25.9
48
44
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
142.3
25.9
27
*
127
Kela drug reimbursment
Transplant complication
19.1
25.7
39
22
GD1AD
NOMESCO Finland
Thorax CT examination
7.5
25.4
62
93
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
8.6
25.3
56
72
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.3
25.1
70
126
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
34.0
24.9
32
10
C03CA01
ATC
furosemide; systemic
2.9
24.9
194
885
TK800
NOMESCO Finland
Hemodialysis
12.9
24.8
44
37
4464A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Wegener's granulomatosis
+∞
24.2
23
*
N18.0
ICD-10 Finland
End-stage renal disease
18.0
23.9
37
22
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
9.0
23.8
51
62
J01MA12
ATC
levofloxacin; systemic
3.2
23.0
140
534
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
42.3
22.9
28
7
WW400
NOMESCO Finland
Plasmaferesis
240.5
22.8
23
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.7
22.2
66
129
Z49.1
ICD-10 Finland
Extracorporeal dialysis
15.4
22.0
36
25
ZX108
NOMESCO Finland
Inhalation
32.8
21.7
28
9
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.0
21.5
72
161
H02AB07
ATC
prednisone; oral
3.4
21.1
114
396
H65.3
ICD-10 Finland
Chronic mucoid otitis media
11.6
21.0
39
36
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
15.8
21.0
34
23
1AA01
NOMESCO Finland
NA
218.6
20.7
21
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
20.4
89
258
137
Kela drug reimbursment
Uraemia requiring dialysis
28.4
20.2
27
10
H65.2
ICD-10 Finland
Chronic serous otitis media
15.3
20.2
33
23
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
19.9
19
*
Z2446
NOMESCO Finland
Social worker
4.6
19.9
72
175
UDM02
NOMESCO Finland
Sinoscopy
9.6
19.5
40
45
M35.3
ICD-10 Finland
Polymyalgia rheumatica
15.6
19.2
31
21
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.3
18.9
51
88
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
18.9
18
*
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
18.9
18
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
18.1
290
1867
N085, M318
ICD-10 Finland
NA
+∞
17.8
17
*
Z49.2
ICD-10 Finland
Other dialysis
25.1
17.5
24
10
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
32.8
17.2
22
7
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.5
17.2
169
846
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.6
17.1
62
150
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.7
17.0
59
137
C08CA01
ATC
amlodipine; oral
2.3
16.9
211
1193
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
13.3
16.8
29
23
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
16.8
16
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.4
16.6
44
74
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.6
16.4
144
671
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.4
16.3
28
22
A02BC01
ATC
omeprazole; systemic
2.4
16.2
169
866
Z49.0
ICD-10 Finland
Preparatory care for dialysis
16.4
15.9
25
16
H26.3
ICD-10 Finland
Drug-induced cataract
62.1
15.9
18
*
M13.9
ICD-10 Finland
Arthritis, unspecified
4.4
15.8
59
147
Z3231
NOMESCO Finland
Registered nurse
2.4
15.6
172
905
L04AD01
ATC
ciclosporin; systemic
8.4
15.6
34
43
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
15.5
108
439
ZXA10
NOMESCO Finland
Bilateral
2.7
15.2
123
545
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.3
15.1
57
144
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
14.8
69
210
J01MA14
ATC
moxifloxacin; systemic
3.5
14.8
74
239
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
14.7
14
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
10.5
14.6
28
28
M05BB03
ATC
alendronic acid and colecalciferol; oral
8.6
14.5
31
38
Z2221
NOMESCO Finland
Medical doctor
2.3
14.4
171
926
WW200
NOMESCO Finland
Immunization
6.9
14.1
35
54
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
13.8
79
282
B03XA01
ATC
erythropoietin; parenteral
13.3
13.5
23
18
M30.0
ICD-10 Finland
Polyarteritis nodosa
143.7
13.5
14
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
11.9
13.4
24
21
B05DA
ATC
Isotonic solutions
21.9
13.4
19
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.2
13.4
32
47
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
15.6
13.2
21
14
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
10.5
13.1
25
25
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.5
12.9
62
194
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
7.3
12.8
30
43
R04.0
ICD-10 Finland
Epistaxis
3.6
12.6
59
180
PAW37
NOMESCO Finland
Biopsy of temporal artery
33.0
12.6
16
5
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.2
12.6
30
44
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.4
12.6
46
113
J01FF01
ATC
clindamycin; systemic
2.2
12.5
154
838
P01BA02
ATC
hydroxychloroquine; oral
3.7
12.5
55
160
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
12.5
201
1229
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
12.3
63
207
J01CA04
ATC
amoxicillin; systemic
2.2
11.8
410
3355
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
11.8
99
444
WX892
NOMESCO Finland
Monitored bed care
3.3
11.8
60
196
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
19.5
11.7
17
9
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
122.7
11.5
12
*
ZXE00
NOMESCO Finland
One hour or less
2.0
11.4
217
1400
J05AB11
ATC
valaciclovir; oral
2.7
11.4
83
343
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
11.4
49
140
L04AA01
ATC
[U] ciclosporin; systemic
9.9
11.3
22
23
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.0
11.2
45
121
C09AA02
ATC
enalapril; systemic
2.3
11.1
119
601
UDC00
NOMESCO Finland
Ear microscopy
3.4
11.1
55
176
3AC01
NOMESCO Finland
NA
14.3
11.0
18
13
M05BA07
ATC
risedronic acid; oral
5.1
11.0
34
70
RS221
NOMESCO Finland
NA
8.1
11.0
24
31
Z3226
NOMESCO Finland
Physiotherapist
2.3
10.8
115
578
XG410
NOMESCO Finland
Flow-volume spirometry
4.4
10.8
39
95
V03AE02
ATC
sevelamer; oral
18.3
10.8
16
9
L88
ICPC
Rheumatoid/seropositive arthritis
5.0
10.6
33
69
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
10.6
55
183
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
10.4
10
*
B05DB
ATC
Hypertonic solutions
19.3
10.3
15
8
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
23.9
10.3
14
6
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.4
10.2
50
159
J01MA02
ATC
ciprofloxacin; systemic
1.9
10.2
203
1320
RD210
NOMESCO Finland
NA
6.7
10.1
25
39
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.7
10.1
25
39
B07.9
ICD-10 Finland
Verruca simplex
5.0
10.1
32
68
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
15.0
10.1
16
11
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
10.0
157
928
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
40.9
10.0
12
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.0
9.9
31
65
ZXA00
NOMESCO Finland
Right side
2.0
9.8
148
864
205
Kela drug reimbursment
Chronic hypertension
2.0
9.8
148
865
1CX01
NOMESCO Finland
NA
56.1
9.7
11
*
ZXD05
NOMESCO Finland
Urgent procedure
1.9
9.6
169
1042
C02CA01
ATC
prazosin; oral
9.4
9.6
19
21
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.2
9.6
29
59
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
15.4
9.6
15
10
R01AD08
ATC
fluticasone; nasal
2.0
9.5
155
928
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
6.8
9.5
23
35
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
101.9
9.4
10
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
30.7
9.4
12
*
M31.2
ICD-10 Finland
Lethal midline granuloma
+∞
9.4
9
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
9.4
9
*
TK820
NOMESCO Finland
Peritoneal dialysis
22.2
9.4
13
6
WX002
NOMESCO Finland
Sedation and analgesia
2.1
9.3
115
619
TAB00
NOMESCO Finland
Lumbar puncture
4.2
9.2
34
85
H65.0
ICD-10 Finland
Acute serous otitis media
8.0
9.2
20
26
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
6.5
9.2
23
37
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
9.1
39
112
TK810
NOMESCO Finland
Hemofiltration
15.9
9.1
14
9
J01DB01
ATC
cefalexin; oral
2.0
9.1
408
3436
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
37.4
9.0
11
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.0
9.0
35
92
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
9.0
208
1405
EB1WA
NOMESCO Finland
NA
19.0
9.0
13
7
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.7
8.9
38
109
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
8.9
59
231
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
8.7
62
253
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
50.9
8.7
10
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
50.9
8.7
10
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
+∞
8.4
8
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.1
8.3
25
51
M05BA06
ATC
ibandronic acid; systemic
7.7
8.2
18
24
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
7.0
8.1
19
28
H02AB09
ATC
hydrocortisone; systemic
5.4
8.1
23
44
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
22.4
8.0
11
5
ZXA05
NOMESCO Finland
Left side
1.9
7.9
132
790
DFF00
NOMESCO Finland
Pure tone audiometry
2.7
7.9
56
226
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.9
7.9
49
183
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
7.7
55
222
DC1AD
NOMESCO Finland
Temporalbone CT
7.6
7.7
17
23
RS222
NOMESCO Finland
NA
8.2
7.6
16
20
6BA02
NOMESCO Finland
NA
18.7
7.6
11
6
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
12.1
7.6
13
11
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
25.4
7.6
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
7.6
112
643
R04.2
ICD-10 Finland
Haemoptysis
3.8
7.5
30
82
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.5
7.5
58
249
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.5
124
741
I77.6
ICD-10 Finland
Arteritis, unspecified
81.2
7.4
8
*
C08CA13
ATC
lercanidipine; oral
2.2
7.4
74
360
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
7.3
7
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
7.2
97
534
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.0
7.2
22
46
N25.0
ICD-10 Finland
Renal osteodystrophy
30.5
7.2
9
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
20.4
7.2
10
5
J05AB01
ATC
aciclovir; systemic
1.9
7.1
107
616
V03AE01
ATC
polystyrene sulfonate; oral
6.2
7.1
18
30
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.8
7.1
19
34
N19
ICD-10 Finland
Unspecified kidney failure
4.1
7.1
26
66
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
7.1
48
189
RS220
NOMESCO Finland
NA
7.1
7.0
16
23
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
7.0
57
250
J47
ICD-10 Finland
Bronchiectasis
6.0
7.0
18
31
R4110
NOMESCO Finland
Physiotherapy
1.8
6.9
141
897
I15.0
ICD-10 Finland
Renovascular hypertension
14.0
6.9
11
8
321
Kela drug reimbursment
Paricalcitol and cinacalcet
14.0
6.9
11
8
196
Kela drug reimbursment
Paricalcitol and cinacalcet
14.0
6.9
11
8
JN4AD
NOMESCO Finland
Body CT examination
2.7
6.9
47
186
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.1
6.8
12
11
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
6.8
33
106
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
6.8
41
153
R4190
NOMESCO Finland
Nutritional therapy
4.1
6.8
25
64
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.1
6.8
25
64
5AB14
NOMESCO Finland
NA
40.6
6.8
8
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
6.7
80
421
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
6.7
191
1346
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
8.0
6.7
14
18
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
6.6
50
213
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.8
6.5
20
43
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
70.7
6.4
7
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
14.5
6.4
10
7
JN4BD
NOMESCO Finland
Extensive body CT
2.2
6.4
61
291
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
6.7
6.4
15
23
K65.0
ICD-10 Finland
Acute peritonitis
6.1
6.3
16
27
J32.4
ICD-10 Finland
Chronic pansinusitis
6.1
6.3
16
27
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.4
6.3
12
13
DHB10
NOMESCO Finland
Excision of lesion of internal nose
18.3
6.3
9
5
V03AE03
ATC
lanthanum carbonate; oral
18.3
6.3
9
5
K06.18
ICD-10 Finland
Another gingival hyperplasia
18.3
6.3
9
5
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
6.3
6
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
27.0
6.2
8
*
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
27.0
6.2
8
*
R01AD09
ATC
mometasone; nasal
1.6
6.2
218
1613
H20.1
ICD-10 Finland
Chronic iridocyclitis
8.7
6.1
12
14
H15.1
ICD-10 Finland
Episcleritis
6.8
6.1
14
21
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
10.2
6.1
11
11
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
6.0
48
208
B01AA03
ATC
warfarin; systemic
1.9
6.0
98
577
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
182
71
37.53
273.74
3.9
1.1
titre
168.6
—
—
79
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
185
94
28.92
251.46
5.2
1.1
iu/ml
13.6
—
—
27
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
155
72
29.40
216.96
7.6
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
85
36
27.67
121.13
4.8
1.1
u/ml
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
170
267
8.71
110.45
2.4
1.6
g/l
0.7
1.3
3.58
162
244
(40768446) Kidney Pathology biopsy report
61
12
56.94
107.12
1.5
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
385
1474
6.18
95.50
18.4
5.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
301
947
5.72
93.83
7.5
2.6
e6/l
3.5
5.8
1.40
291
839
(3001604) Monocytes [#/volume] in Blood
469
2211
7.96
89.27
20.9
5.5
e9/l
0.7
0.6
6.80
451
1915
(3006315) Basophils [#/volume] in Blood
470
2223
8.00
89.04
20.9
5.5
e9/l
0.0
0.0
0.05
451
1929
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
108
127
10.30
87.65
2.6
1.1
g/l
1.2
1.2
0.07
101
122
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
110
134
9.98
86.89
1.7
1.5
iu/ml
0.7
0.1
0.52
19
25
(3019198) Lymphocytes [#/volume] in Blood
470
2269
7.73
85.50
21.0
5.6
e9/l
1.6
1.9
4.62
455
2009
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
93
92
11.93
85.26
6.5
7.6
iu/ml
574.5
359.3
0.30
13
15
(3013115) Eosinophils [#/volume] in Blood
470
2301
7.55
83.11
21.7
5.9
e9/l
0.2
0.2
3.15
452
2033
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
390
1642
5.55
82.37
13.4
3.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
207
537
5.53
78.85
1.7
1.3
titre
367.0
348.5
0.09
46
111
(3017143) Hepatitis C virus Ab [Presence] in Serum
198
498
5.61
78.07
2.0
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
161
343
6.19
76.05
9.4
3.9
ng/l
118.4
86.1
3.16
153
305
(3024980) IgG subclass 4 [Mass/volume] in Serum
75
68
12.58
72.51
1.9
1.7
g/l
0.7
0.7
0.11
54
54
(3024139) IgG subclass 3 [Mass/volume] in Serum
60
37
18.05
72.05
1.7
1.4
g/l
0.3
0.4
0.03
39
27
(3027135) IgG subclass 1 [Mass/volume] in Serum
60
37
18.05
72.05
1.7
1.4
g/l
6.3
6.3
0.02
41
27
(3028192) IgG subclass 2 [Mass/volume] in Serum
60
37
18.05
72.05
1.8
1.4
g/l
2.4
2.6
0.19
41
27
(3026782) Osmolality of Urine
265
896
4.72
71.85
8.1
2.8
mosm/kgh2o
532.5
553.6
0.96
253
766
(3002582) Erythrocytes [#/volume] in Urine
340
1389
4.70
71.63
11.0
3.1
e6/l
29.7
97.2
0.80
320
1064
(3018095) Leukocytes [#/volume] in Urine
370
1621
4.79
70.70
12.9
3.6
e6/l
39.1
89.7
1.23
324
1146
(36304419) Bacteria [Presence] in Urine
316
1235
4.59
70.34
10.6
2.9
—
—
—
0
0
(4062490)
60
39
17.11
70.14
1.9
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
215
635
4.88
68.89
2.0
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
387
1791
4.77
67.72
3.7
2.3
nmol/l
80.3
76.9
1.73
382
1608
(3021879) Hepatitis B virus core Ab [Presence] in Serum
146
320
5.82
66.23
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
472
2592
6.28
64.97
23.4
9.4
e9/l
4.9
4.1
6.53
455
2285
(3030467) Casts [#/volume] in Urine by Automated count
307
1274
4.13
60.59
11.2
3.0
e6/l
0.1
0.5
4.19
287
954
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
421
2195
4.72
59.65
18.2
6.9
mmol/l
1.2
1.2
0.80
364
1862
(3021601) Nitrite [Presence] in Urine by Test strip
420
2194
4.68
59.14
12.1
4.9
estimate
0.0
0.0
0.00
109
409
(3018418) pH of Serum or Plasma
313
1342
4.03
58.35
11.0
4.0
ph
7.4
7.4
0.22
60
248
(3017181) Myelocytes/100 leukocytes in Blood
150
374
5.11
58.18
7.1
4.0
%
0.9
1.0
0.16
63
123
(3009261) Glucose [Presence] in Urine by Test strip
421
2222
4.62
57.94
8.9
3.6
estimate
0.0
0.0
0.50
107
391
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
197
613
4.42
57.70
4.5
2.3
%
22.8
22.5
0.08
177
527
(3035350) Ketones [Presence] in Urine by Test strip
417
2197
4.54
57.24
9.0
3.6
estimate
0.0
0.0
0.00
107
411
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
395
2006
4.30
57.06
15.1
6.1
mmol/l
1.2
1.2
0.75
382
1815
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
54
42
14.13
57.04
2.0
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
143
349
5.16
56.80
7.3
4.1
%
0.1
0.2
0.68
60
111
(3007853) Bacteria identified in Skin by Aerobe culture
176
519
4.49
55.07
2.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
68
83
9.19
52.87
1.7
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
136
337
5.01
52.78
7.0
4.0
%
0.5
0.4
0.04
44
87
(3004789) Transferrin [Mass/volume] in Serum or Plasma
195
651
4.06
51.08
4.3
2.3
g/l
2.1
2.3
6.64
189
603
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
86
145
6.83
50.44
2.9
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
204
710
3.95
50.23
4.2
2.3
umol/l
11.7
13.0
2.00
198
654
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
72
103
7.88
49.03
1.6
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
297
1340
3.60
48.98
9.7
3.2
mg/l
388.9
154.7
0.52
256
878
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
94
181
6.04
48.20
3.1
2.1
g/l
1.6
1.5
0.68
82
162
(3025159) Blasts/100 leukocytes in Blood
128
329
4.75
47.15
7.7
4.1
%
0.2
0.2
0.07
52
92
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
158
482
4.18
46.46
3.5
4.4
u/l
257.6
245.3
0.35
150
458
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
93
185
5.83
46.00
1.6
2.2
u/l
30.9
39.8
4.40
86
167
(46235355) HIV 1 and 2 tests - Meaningful Use set
206
763
3.69
45.63
2.1
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
63
9.57
44.75
1.8
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
299
1429
3.35
43.53
11.7
3.9
mg/mmol
15.2
10.1
1.42
258
909
(3011397) Hemoglobin [Presence] in Urine by Test strip
239
1007
3.40
42.71
8.4
3.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
477
3085
4.72
42.11
15.4
4.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
68
108
7.03
42.00
5.1
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
298
1446
3.27
41.84
10.0
3.0
mmol/l
6.9
7.7
2.55
285
1211
(3030905) Polymorphonuclear cells [#/volume] in Blood
54
66
8.95
41.74
5.4
2.5
e9/l
4.8
4.5
0.19
54
66
(3023368) Bacteria identified in Blood by Culture
273
1266
3.26
41.27
6.2
4.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
52
62
9.14
40.97
1.8
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
182
665
3.58
40.52
2.4
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
364
2012
3.32
40.44
24.9
9.4
e9/l
0.0
0.0
0.27
332
1647
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
70
8.43
39.79
5.5
2.9
%
60.2
59.3
0.14
54
70
(3027945) Reticulocytes/100 erythrocytes in Blood
152
499
3.81
39.70
3.9
2.8
%
1.9
1.8
0.60
144
455
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
198
777
3.40
39.18
8.6
2.7
e6/l
0.3
1.1
9.05
154
435
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
194
752
3.42
39.15
2.3
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
31
18
18.17
37.88
1.3
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
66
114
6.43
37.52
2.0
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
64
108
6.56
37.21
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
152
521
3.63
36.97
2.1
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
52
71
7.97
36.64
1.8
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
39
37
11.26
36.14
2.2
2.1
e9/l
1.1
0.9
0.46
22
17
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
89
211
4.83
35.72
10.6
3.9
mmol/l
24.0
24.1
0.13
83
193
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
136
5.74
35.22
1.7
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
150
525
3.54
35.16
2.2
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
204
867
3.13
34.66
2.1
1.4
g/l
2.1
2.5
2.53
168
527
(3036481) Cortisol [Moles/volume] in Serum or Plasma
127
403
3.78
34.47
2.2
1.9
nmol/l
318.0
381.1
3.45
122
371
(40758558) Short blood count panel - Blood
242
1136
2.99
34.39
16.1
7.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
485
3364
4.34
34.25
16.0
3.8
mm/h
14.5
11.9
3.53
476
3092
(3002032) Base excess in Venous blood by calculation
131
430
3.67
33.76
9.3
3.8
mmol/l
1.7
1.9
0.33
119
340
(3000991) Gas panel - Venous blood
119
369
3.83
33.33
15.1
8.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
48
67
7.74
33.14
2.1
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
65
125
5.75
33.01
1.7
2.2
mg/l
10.0
12.0
0.99
58
116
(3023520) Reticulocytes [#/volume] in Blood
118
368
3.80
32.74
3.1
2.8
e9/l
69.0
71.8
0.28
65
292
(3012544) pH of Venous blood
131
441
3.57
32.39
9.2
3.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
492
3509
4.35
31.87
19.3
7.6
u/l
71.3
79.2
6.44
487
3285
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
81
6.83
31.32
2.1
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
40
49
8.72
30.72
2.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
50
80
6.77
30.48
1.4
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
25
12.62
30.10
2.3
2.0
%
21.1
14.0
0.50
14
13
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
22
10
22.86
29.69
1.3
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
173
734
2.97
28.71
9.5
2.8
e6/l
1.3
2.3
1.76
129
394
(3037121) Protein [Mass/volume] in Urine
72
172
4.66
28.42
7.1
3.4
g/l
0.4
0.3
0.60
52
69
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
30
10.88
28.24
2.0
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
15
16.67
28.15
2.5
2.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
91
264
3.92
27.78
1.6
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
28
24
12.23
27.57
2.1
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
25
11.74
26.86
2.1
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
43
67
6.87
26.83
2.5
3.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
20
10
20.71
25.89
6.2
4.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
63
6.76
24.68
1.3
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
137
553
2.96
24.46
2.0
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
26
24
11.31
24.38
2.6
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
225
1174
2.53
24.14
4.5
2.8
umol/l
357.5
7591.1
5.03
216
1023
(3031040) Bacteria [#/volume] in Urine by Automated count
421
2945
2.74
23.72
8.6
4.4
e6/l
11579.0
3505.6
—
9
48
(3012095) Magnesium [Moles/volume] in Serum or Plasma
159
712
2.72
23.22
4.2
3.6
mmol/l
0.8
0.8
0.15
153
674
(3042631) Mycobacterium sp identified in Specimen
38
65
6.20
21.63
2.4
3.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
35
8.37
21.06
2.1
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
192
996
2.41
20.19
14.5
4.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
28
37
7.91
20.12
2.6
3.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
139
4.28
20.08
1.2
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
139
4.28
20.08
1.2
2.4
g/l
7.6
7.4
0.50
41
103
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
139
4.28
20.08
1.2
2.4
g/l
3.8
3.8
0.18
40
98
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
19
0
+∞
19.91
1.1
0.0
iu/ml
42.4
—
—
11
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
352
2380
2.29
19.48
7.1
6.6
umol/l
10.3
11.5
1.55
346
2261
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
52
129
4.34
19.44
4.3
2.4
u/ml
0.4
0.3
0.34
29
69
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
125
4.39
19.36
1.2
2.6
g/l
9.1
10.6
2.06
45
108
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
40
80
5.31
19.32
3.9
2.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
26
33
8.21
19.30
2.5
2.1
e6/l
477.7
512.2
0.11
16
14
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
41
84
5.19
19.28
1.5
1.1
u/ml
43.0
3.7
—
6
8
(21494814) CD8 cells/100 lymphocytes in Specimen
16
10
16.44
18.57
1.8
2.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
79
271
3.23
18.40
1.7
1.2
u/ml
121.1
254.7
0.81
74
245
(3033658) Prothrombin time (PT) actual/Normal
205
1135
2.27
18.19
6.7
3.9
%
96.4
90.7
2.53
198
1113
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
48
118
4.36
18.14
1.7
4.8
ratio
1.1
2.1
—
7
15
(3052851) Hemolysis interference index of Serum or Plasma
50
127
4.23
18.11
3.2
2.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
48
119
4.32
17.94
1.9
4.9
mg/l
60.4
112.5
0.42
39
89
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
48
119
4.32
17.94
1.8
4.9
mg/l
47.7
31.0
1.01
39
90
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
83
4.98
17.55
2.0
1.4
u/ml
116.7
101.7
—
6
16
(3015377) Calcium [Moles/volume] in Serum or Plasma
248
1510
2.15
17.13
4.3
3.3
mmol/l
2.3
2.4
1.44
235
1326
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
93
4.68
17.11
1.9
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
129
4.07
16.91
1.2
2.5
g/l
3.3
3.1
0.65
40
100
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
35
70
5.27
16.89
1.6
1.1
u/ml
85.0
5.9
—
5
6
(3029937) Albumin [Presence] in Urine by Test strip
208
1189
2.19
16.81
10.9
3.8
estimate
0.0
0.0
0.50
104
401
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
356
2.86
16.80
3.6
2.8
ml/min/173m2
59.7
65.2
0.56
46
153
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
93
4.56
16.20
1.4
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
246
1520
2.10
16.09
4.3
3.5
u/l
26.5
33.4
4.66
240
1451
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
125
4.01
15.99
1.5
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
26
41
6.60
15.96
1.1
1.2
—
—
—
0
0
(44790049)
30
55
5.71
15.88
1.8
1.5
—
—
—
0
0
(44806118)
30
55
5.71
15.88
1.8
1.5
—
—
—
0
0
(44790048)
30
55
5.71
15.88
1.8
1.5
—
—
—
0
0
(44790047)
30
55
5.71
15.88
1.8
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
60
190
3.42
15.84
2.6
1.9
ug/l
2.5
2.7
0.04
55
170
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
72
4.96
15.38
1.1
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
14
11.74
15.37
1.8
2.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
50
5.84
15.22
3.1
4.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
44
6.15
14.91
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
222
1357
2.05
14.61
3.7
3.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
87
4.35
13.88
1.4
1.4
u/ml
296.9
283.3
0.07
26
53
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
51
5.51
13.84
6.1
3.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
89
379
2.60
13.82
11.5
3.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
284
1940
1.94
13.22
4.6
2.7
ug/l
178.8
131.3
2.04
277
1794
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
46
5.64
13.17
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
36
91
4.16
13.10
2.1
5.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
362
2698
1.97
12.84
8.5
4.9
mmol/l
6.6
6.7
0.35
351
2525
(40768804) Tissue Pathology biopsy report
267
1811
1.91
12.47
2.6
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
170
990
2.03
12.42
2.6
1.7
mg/l
2.0
1.3
1.56
146
775
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
67
263
2.76
12.17
1.9
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
134
724
2.12
11.92
1.3
1.2
iu/ml
28.6
35.7
0.62
58
221
(3008536) Aspergillus sp Ab [Presence] in Serum
14
15
9.55
11.70
1.7
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
253
1715
1.87
11.59
10.3
3.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
48
5.18
11.57
1.1
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
183
1119
1.94
11.48
2.8
2.1
mg/l
3.0
3.1
0.26
164
961
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
68
280
2.63
11.24
6.9
3.7
mmol/l
1.3
1.7
0.51
52
210
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
96
464
2.29
11.21
3.5
3.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
34
93
3.83
11.12
5.1
4.0
mmol/l
2.5
2.7
0.11
22
60
(3041096) Erythrocytes [Presence] in Urine by Automated
195
1231
1.90
11.03
8.5
3.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
267
1872
1.82
10.71
12.2
9.0
inr
1.1
1.2
0.95
89
547
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
17
8.42
10.65
2.4
6.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
20
7.68
10.60
1.1
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
52
4.78
10.57
2.3
2.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
153
3.11
10.56
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
92
3.75
10.52
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
92
3.75
10.52
1.5
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
27
6.46
10.32
4.4
3.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
204
1330
1.84
10.29
2.5
2.1
u/l
114.4
267.7
1.95
195
1244
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
35
104
3.52
10.17
1.7
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
33
95
3.63
10.04
5.4
3.2
—
—
—
0
0
(3009343) pH of Capillary blood
68
296
2.48
10.00
7.0
3.6
ph
7.4
7.4
—
10
35
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
60
4.31
9.73
1.1
1.2
u/ml
3.0
4.0
—
6
24
(3003396) Base excess in Arterial blood by calculation
100
520
2.12
9.68
11.9
8.1
mmol/l
0.9
1.2
0.37
81
410
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
22
48
4.73
9.61
2.1
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
72
329
2.36
9.52
1.5
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
124
703
1.98
9.48
1.3
1.2
u/ml
6.1
12.1
0.84
51
266
(3022313) Gas panel - Capillary blood
55
223
2.63
9.36
6.8
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
79
379
2.26
9.33
12.5
3.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
58
4.28
9.26
1.1
1.2
u/ml
7.4
2.7
—
7
16
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
51
4.45
8.94
2.1
2.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
28
5.85
8.85
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
106
3.25
8.51
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
512
4557
2.47
8.46
42.2
14.1
mg/l
19.1
24.1
4.70
487
3602
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
107
3.21
8.39
1.1
1.1
—
—
—
0
0
(4035726)
77
386
2.15
8.14
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
14
7.99
8.01
1.6
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
35
4.98
7.93
1.4
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
35
4.98
7.93
1.2
1.2
u/ml
0.5
0.1
—
9
18
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
39
4.74
7.93
1.6
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
32
5.12
7.70
2.8
3.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
36
4.84
7.68
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
36
4.84
7.68
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
36
4.84
7.68
1.4
3.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
37
4.71
7.45
4.5
3.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
33
4.96
7.45
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
33
4.96
7.45
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
33
4.96
7.45
1.5
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
33
4.96
7.45
3.1
2.5
%
49.0
43.3
—
6
10
(40767503) Oxygen content in Capillary blood by calculation
28
90
3.22
7.23
3.7
2.3
%
16.2
16.3
0.05
13
46
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
15
30
5.11
7.22
1.9
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
34
4.82
7.20
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
34
4.82
7.20
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
34
4.82
7.20
1.5
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
16
6.99
7.17
1.1
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
8
13.99
6.91
2.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
24
5.52
6.80
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
25
5.30
6.52
1.5
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
131
842
1.73
6.49
2.8
2.9
mmol/l
2.5
2.5
0.97
119
742
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
46
4.01
6.48
1.5
1.3
%
42.0
70.2
—
10
37
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
7
14.51
6.41
1.1
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
7
14.51
6.41
2.4
1.1
%
86.3
89.6
—
10
7
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
7
14.51
6.41
2.4
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
15
6.77
6.33
1.1
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
77
424
1.95
6.29
2.0
2.4
u/l
36.2
31.8
0.66
71
358
(4027681)
13
26
5.10
6.25
1.2
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
8
12.70
6.10
1.6
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
24
79
3.13
5.99
1.9
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
10
16
6.35
5.97
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
233
2.21
5.91
14.0
11.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
43
194
2.32
5.86
1.1
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
9
11.29
5.81
1.1
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
14
32
4.46
5.79
1.7
1.3
%
41.3
23.9
—
8
25
(3022806) Fractional oxyhemoglobin in Capillary blood
19
55
3.54
5.78
1.9
1.7
%
87.0
89.9
0.67
19
55
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
67
362
1.97
5.77
3.3
3.3
ng/l
107.0
211.2
2.94
62
330
(3044941) Cell count panel - Synovial fluid
22
71
3.18
5.67
1.9
1.4
—
—
—
0
0
(4268621)
15
37
4.14
5.66
2.1
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
59
308
2.02
5.60
4.6
6.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
42
3.89
5.57
1.6
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
29
111
2.70
5.56
1.4
1.3
mg/l
518.1
473.7
0.31
29
103
(3019309) Folate [Moles/volume] in Red Blood Cells
125
826
1.66
5.52
1.8
1.7
nmol/l
1184.9
1197.9
0.05
109
634
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
5
16.21
5.42
1.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
108
2.68
5.30
2.2
1.5
e6/l
12915.8
13812.6
0.04
22
78
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
12
26
4.69
5.28
1.0
1.2
mmol/l
2.0
2.0
0.02
12
26
(3049717) Cytology report of Urine Cyto stain
38
171
2.31
5.23
2.8
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
86
2.87
5.20
1.5
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
45
3.63
5.08
2.7
3.2
%
75.2
59.7
2.41
11
32
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
117
2.56
5.04
1.8
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
124
2.50
4.97
1.3
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
20
67
3.06
4.87
9.8
6.3
mg/l
13.4
11.0
1.47
20
61
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
10
9.12
4.80
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
43
3.56
4.64
1.4
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
187
2.17
4.64
2.9
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
48
3.40
4.63
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
48
3.40
4.63
1.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
48
3.40
4.63
1.7
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
25
98
2.62
4.61
11.4
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
177
1316
1.50
4.61
3.2
3.1
ng/l
1528.3
1287.4
0.31
164
1126
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
8
10.12
4.53
1.6
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
509
4715
1.89
4.51
38.5
16.4
mmol/l
139.7
139.7
0.02
504
4593
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
232
1829
1.46
4.47
2.0
2.0
pmol/l
94.5
95.3
0.10
132
958
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
267
2162
1.45
4.47
4.8
4.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
82
2.75
4.47
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
510
4733
1.88
4.41
39.1
16.5
mmol/l
4.0
4.0
0.03
505
4600
(3019225) pH of Specimen
69
413
1.77
4.33
12.0
4.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
61
3.02
4.32
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
6
11.79
4.28
1.0
1.0
—
—
—
0
0
(4010399)
60
346
1.82
4.26
1.6
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
103
2.49
4.19
3.2
2.0
g/l
125.3
131.0
0.53
16
77
(3013727) Leukocytes other/100 leukocytes in Blood
9
13
7.01
4.17
3.3
4.2
%
61.3
49.1
—
9
13
(3045424) Erythrocytes [Presence] in Urine
20
74
2.77
4.13
1.7
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
147
1075
1.50
4.08
1.6
1.5
nmol/l
17.7
20.9
2.53
140
916
(3019832) Treponema pallidum Ab [Presence] in Serum
62
367
1.78
4.05
1.6
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
124
2.32
4.03
1.5
1.4
miu/ml
166.2
238.9
—
7
60
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
7
10.11
4.02
1.1
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
7
10.11
4.02
1.6
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
189
1462
1.44
3.92
3.6
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
126
900
1.52
3.90
4.3
4.0
ng/l
172.0
312.4
0.82
107
709
(3034426) Prothrombin time (PT)
8
11
7.36
3.87
1.0
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
8
8.84
3.78
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
8
8.84
3.78
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
71
446
1.68
3.76
1.9
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
90
2.50
3.76
1.5
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
21
84
2.56
3.75
4.2
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
266
0.33
3.65
1.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
62
2.80
3.62
1.5
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
147
1099
1.46
3.61
3.5
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
134
984
1.48
3.61
10.5
3.8
kg/l
1.0
1.0
0.21
12
141
(1761868) Lipid panel - Serum or Plasma
125
1667
0.68
3.58
2.7
2.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
57
2.86
3.55
2.7
2.1
pg
32.3
33.1
0.27
16
57
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
26
3.90
3.53
1.8
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
26
3.90
3.53
1.8
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
26
3.90
3.53
1.8
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
26
3.90
3.53
1.8
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
162
1244
1.43
3.43
2.0
1.7
mmol/l
1.4
1.4
0.04
147
1056
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
396
0.41
3.42
1.1
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
18
5.06
3.38
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
32
3.49
3.35
9.6
1.8
%
10.7
11.7
0.37
11
32
(21494755) Public health laboratory ask at order entry panel
19
419
0.43
3.34
1.2
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
38
3.21
3.23
1.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
74
2.48
3.07
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
29
3.49
3.06
4.5
2.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
183
1.91
3.03
2.4
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
215
1768
1.35
2.94
4.3
3.6
ng/l
38.4
60.5
0.50
168
1236
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
22
4.14
2.89
1.1
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
22
4.14
2.89
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
464
4309
1.45
2.79
34.2
13.0
ml/min/173m2
71.5
81.1
11.14
432
3548
(3036048) Francisella tularensis Ab [Titer] in Serum
5
6
8.39
2.75
1.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
10
6.05
2.70
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
19
4.26
2.68
2.0
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
19
4.26
2.68
2.0
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
19
4.26
2.68
2.0
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
456
4232
1.42
2.65
6.8
5.8
mmol/mol
39.4
39.9
0.29
442
3945
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
75
523
1.50
2.59
2.7
3.1
umol/l
6.9
9.9
1.05
65
466
(3020891) Body temperature
33
186
1.82
2.59
6.6
4.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
44
2.77
2.56
4.6
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
281
1.65
2.49
1.6
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
45
2.70
2.46
1.3
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
45
2.70
2.46
1.8
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
174
1418
1.33
2.45
2.7
2.6
u/l
61.7
55.2
2.16
167
1314
(3044889) 12 lead EKG panel
359
3231
1.31
2.42
4.6
3.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
90
2.15
2.41
2.6
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
8
6.29
2.37
1.2
1.0
miu/ml
1334.0
1338.3
—
5
8
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
65
2.34
2.33
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
13
4.65
2.27
2.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
24
3.37
2.18
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
24
3.37
2.18
1.1
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
24
3.37
2.18
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
14
4.32
2.15
2.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
418
4455
0.76
2.13
5.5
4.5
mmol/l
5.7
6.0
3.57
398
4088
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
62
2.29
2.09
1.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
20
3.53
2.06
1.6
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
170
1.74
2.04
2.1
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
26
3.11
2.02
1.1
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
32
2.84
2.01
1.3
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
21
3.36
1.97
1.4
1.0
iu/ml
414.3
199.6
—
7
21
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
11
4.58
1.94
1.0
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
11
4.58
1.94
1.2
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
11
4.58
1.94
1.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
27
2.99
1.94
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
12
4.19
1.82
1.2
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
53
2.29
1.82
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
23
3.07
1.80
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
499
4780
1.41
1.75
28.4
13.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
42
2.41
1.68
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
55
2.21
1.68
1.3
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
19
3.18
1.66
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
7
25
2.82
1.65
1.1
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
221
0.49
1.59
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
44
2.30
1.54
1.2
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
43
0.00
1.52
0.0
1.0
—
4.5
—
0
16
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
27
2.61
1.52
2.1
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
21
2.88
1.51
1.7
2.0
—
—
—
0
0
(4306422)
12
58
2.09
1.50
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
156
1.63
1.46
1.1
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
52
2.14
1.45
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
42
580
0.70
1.41
1.3
1.7
%
1.5
1.5
0.22
36
520
(3035637) Corticotropin [Mass/volume] in Plasma
10
46
2.20
1.40
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
285
0.58
1.39
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
41
2.21
1.37
1.1
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
17
2.96
1.36
11.4
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
17
2.96
1.36
11.4
3.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
37
0.00
1.35
0.0
20.9
—
1595.9
—
0
37
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
308
2828
1.20
1.33
3.3
3.0
—
—
—
0
0
(3002256) Pathology report gross observation
71
557
1.31
1.31
1.8
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
24
2.52
1.30
2.7
4.4
%
108.0
99.3
—
6
24
(3050129) First trimester maternal screen panel - Serum or Plasma
5
115
0.43
1.26
1.8
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
11
56
1.98
1.23
5.9
11.4
mmol/l
6.8
6.7
0.07
11
46
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.0
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
26
173
1.53
1.20
6.5
4.1
mmol/l
1.3
1.4
0.48
26
168
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
57
1.95
1.17
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
284
1.40
1.16
3.7
2.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
949
1.23
1.11
1.5
1.7
pmol/l
103846582.8
432.6
0.75
104
792
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
194
0.56
1.11
1.6
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
10
181
0.54
1.10
4.3
1.9
mg/l
5.3
3.0
—
5
130
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
145
1.54
1.07
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
137
1.55
1.07
2.4
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
33
2.14
1.06
2.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
33
2.14
1.06
2.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
33
2.14
1.06
2.1
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
50
388
1.32
1.02
2.1
2.4
ug/l
4.8
6.6
0.49
40
346
(4024509)
7
35
2.01
1.00
2.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
148
1.51
0.99
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
211
0.61
0.98
1.8
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
6
27
2.24
0.93
3.8
2.2
min
495.0
491.5
—
6
16
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
27
2.24
0.93
1.7
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
52
1.74
0.92
1.2
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
52
1.74
0.92
1.3
1.3
nmol/l
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
126
1.53
0.92
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
28
2.15
0.91
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
94
1.61
0.91
3.6
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
76
905
0.81
0.90
2.5
3.0
ug/l
0.7
0.8
0.25
59
595
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
135
1.50
0.90
1.4
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
444
0.75
0.86
1.7
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
31
1.95
0.84
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
65
1.71
0.83
2.6
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
46
1.75
0.83
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
114
1.51
0.80
2.8
2.3
u/l
19878.8
4654.1
—
6
43
(3020491) Glucose [Moles/volume] in Blood
6
33
1.83
0.79
2.3
2.1
mmol/l
6.7
6.9
—
6
23
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
25
2.01
0.73
1.2
1.5
u/field
1.4
1.7
—
5
16
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
143
1.41
0.71
1.3
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
5
26
1.93
0.71
1.0
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
518
5084
1.26
0.70
53.5
20.9
e9/l
263.0
247.2
5.81
513
4965
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
484
0.79
0.70
1.7
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
28
1.79
0.66
1.6
4.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
518
5088
1.25
0.66
53.5
20.9
e12/l
4.3
4.5
10.95
511
4958
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
16
224
0.71
0.65
2.4
3.0
u/ml
37.2
42.9
0.14
16
214
(3010813) Leukocytes [#/volume] in Blood
518
5090
1.24
0.64
53.5
20.9
e9/l
7.5
6.7
11.90
512
4959
(3000963) Hemoglobin [Mass/volume] in Blood
518
5091
1.24
0.63
53.7
21.0
g/l
130.2
135.9
13.95
513
5016
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
104
1.45
0.63
1.6
1.7
iu/l
5.3
7.4
—
6
29
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
104
0.57
0.62
1.5
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
49
1.64
0.62
1.5
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
30
1.67
0.61
1.6
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
30
1.67
0.61
1.4
3.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.6
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
450
4614
0.87
0.60
5.5
4.9
mmol/l
2.7
2.7
0.95
430
4265
(3020874) Milk IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.1
—
0
8
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
112
1243
0.88
0.60
3.7
4.3
%
22.2
21.4
0.23
57
591
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
35
1.72
0.58
1.8
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
35
1.72
0.58
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
139
1269
1.13
0.57
1.7
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
54
1.49
0.57
1.3
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
54
1.49
0.57
1.5
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
125
0.63
0.55
1.3
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
357
3439
1.11
0.53
4.2
3.8
pmol/l
15.0
14.8
0.82
329
3107
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
97
0.61
0.52
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
97
0.61
0.52
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
97
0.61
0.52
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
97
0.61
0.52
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
135
0.66
0.52
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
83
1.46
0.52
1.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
429
4175
1.12
0.51
41.5
15.3
%
38.5
40.1
3.34
304
3009
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
101
1.40
0.50
4.4
4.3
mg/l
25.4
29.1
—
7
63
(3025941) Bacteria identified in Stool by Culture
31
253
1.24
0.49
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
41
484
0.84
0.49
3.1
4.2
ug/l
9.2
37.3
0.89
34
410
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
47
1.50
0.47
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
87
782
1.13
0.47
1.7
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
82
0.61
0.46
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
82
0.61
0.46
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
82
0.61
0.46
2.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
84
0.59
0.46
1.4
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
158
1.28
0.42
1.6
1.6
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
86.8
—
0
9
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
59
1.36
0.41
1.1
2.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
548
0.86
0.40
12.8
6.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
61
542
1.14
0.40
2.0
2.3
ug/g
180.6
129.7
0.33
53
428
(3022145) Colonoscopy Study observation
57
504
1.15
0.40
1.3
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.2
—
0
5
(3027944) Amphetamines [Presence] in Urine
13
170
0.76
0.38
1.5
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
426
4349
0.91
0.38
4.6
4.0
mmol/l
1.4
1.3
1.61
406
4002
(3011288) Drugs identified in Urine by Screen method
8
111
0.72
0.37
1.8
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
169
0.76
0.37
1.5
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
168
0.77
0.36
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
168
0.77
0.36
1.5
1.4
—
—
—
0
0
(4094501)
16
126
1.28
0.35
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
147
1559
0.92
0.34
4.1
4.8
ug/l
2.5
2.3
0.21
131
1403
(3023511) Choriogonadotropin [Units/volume] in Urine
11
82
1.35
0.34
1.5
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
18
221
0.81
0.34
1.1
1.1
—
6.2
—
0
5
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
57
632
0.89
0.33
1.4
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
132
0.75
0.32
7.6
4.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
230
1.18
0.31
9.5
4.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
98
0.71
0.31
2.1
2.0
pmol/l
187.1
231.1
—
7
91
(3022217) INR in Platelet poor plasma by Coagulation assay
63
576
1.11
0.28
33.8
23.5
inr
1.4
1.3
—
6
76
(3013512) EKG study
140
1331
1.07
0.26
3.6
3.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
72
1.25
0.25
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
72
1.25
0.25
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
159
0.81
0.25
1.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
37
331
1.13
0.24
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
444
4500
0.94
0.24
5.1
4.4
mmol/l
1.5
1.4
2.66
424
4165
(3012441) Differential panel - Pleural fluid
5
39
1.28
0.23
1.6
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
41
1.22
0.22
1.6
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
239
1.14
0.21
1.3
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
126
1.20
0.21
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
43
1.16
0.21
1.4
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
46
422
1.10
0.21
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
17
198
0.85
0.21
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
111
0.81
0.20
1.1
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
7
58
1.21
0.18
2.0
1.4
nmol/l
0.3
0.4
—
7
46
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
61
1.15
0.17
2.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
61
1.15
0.17
2.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
2.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
2.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
2.0
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
62
1.13
0.17
2.0
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
448
4526
0.95
0.17
5.2
4.4
mmol/l
4.7
4.6
0.28
427
4214
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
173
0.86
0.17
1.5
1.5
—
—
—
0
0
(4034850)
13
151
0.86
0.16
32.6
11.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
80
0.75
0.15
1.3
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
412
4165
0.96
0.15
4.9
4.6
mu/l
1.9
2.2
0.42
386
3802
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
98
0.81
0.14
2.1
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
242
0.91
0.13
1.7
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
63
600
1.06
0.12
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
168
0.89
0.12
2.5
1.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
5
45
1.11
0.10
11.2
3.6
mg/l
87.1
16.6
—
5
32
(3025130) Human papilloma virus identified in Specimen
6
56
1.07
0.08
1.8
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
309
3058
1.02
0.08
3.8
3.2
u/l
60.8
49.4
0.45
298
2864
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
234
1.07
0.08
2.1
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
73
0.82
0.07
10.5
2.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
110
1.09
0.05
1.7
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
102
1005
1.02
0.04
1.2
1.2
u/ml
0.6
1.3
1.55
23
274
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
29
283
1.03
0.01
1.4
1.2
iu/ml
287.6
163.3
—
10
112
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
554
0.99
0.00
4.3
4.5
%
32.8
31.6
0.43
47
374
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
52
523
0.99
0.00
1.7
1.7
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
18.0
—
0
7
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
130
1.00
0.00
1.8
1.5
ug/g
280.1
286.3
—
8
73
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
56
0.89
0.00
1.0
1.1
g/l
1.5
1.5
—
5
51
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
0.3
—
0
6
(40768800) Prostate Pathology biopsy report
9
93
0.97
0.00
1.1
1.1
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
74
0.95
0.00
3.1
2.6
u/ml
3.7
59.2
—
7
69
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
79
1.01
0.00
1.4
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_WEGENER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_WEGENER | 2.443 [2.07, 2.88] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.026 |
During the follow-up period (1.1.1998 — 31.12.2019), 351 out of 1165 females with M13_WEGENER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_WEGENER | 2.398 [2.01, 2.86] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 368 out of 1088 males with M13_WEGENER died.
Mortality risk
Mortality risk for people of age
years, who have M13_WEGENER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.245% | 0.406% |
| 5 | 1.471% | 2.311% |
| 10 | 3.471% | 6.235% |
| 15 | 6.26% | 11.394% |
| 20 | 10.164% | 18.006% |
Relationships between endpoints
↥Index endpoint: M13_WEGENER – Wegener granulomatosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data